These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26975703)

  • 1. Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.
    Honda Y; Shishido T; Takahashi T; Watanabe T; Netsu S; Kinoshita D; Narumi T; Kadowaki S; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Kishida S; Kadomatsu K; Takeishi Y; Kubota I
    Hypertension; 2016 May; 67(5):857-65. PubMed ID: 26975703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II.
    Peng K; Tian X; Qian Y; Skibba M; Zou C; Liu Z; Wang J; Xu Z; Li X; Liang G
    J Cell Mol Med; 2016 Mar; 20(3):482-94. PubMed ID: 26762600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy.
    Yin J; Lu Z; Wang F; Jiang Z; Lu L; Miao N; Wang N
    J Cell Mol Med; 2016 Jun; 20(6):1106-17. PubMed ID: 26923216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
    Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury.
    Takahashi H; Takeishi Y; Arimoto T; Shishido T; Konta T; Koyama Y; Niizeki T; Kubota I
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):487-93. PubMed ID: 16160602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB1 cannabinoid receptor deficiency promotes cardiac remodeling induced by pressure overload in mice.
    Liao Y; Bin J; Luo T; Zhao H; Ledent C; Asakura M; Xu D; Takashima S; Kitakaze M
    Int J Cardiol; 2013 Sep; 167(5):1936-44. PubMed ID: 22656047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
    Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
    Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
    Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.
    Grisanti LA; Repas AA; Talarico JA; Gold JI; Carter RL; Koch WJ; Tilley DG
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H316-30. PubMed ID: 25485901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy.
    Schreier B; Rabe S; Schneider B; Bretschneider M; Rupp S; Ruhs S; Neumann J; Rueckschloss U; Sibilia M; Gotthardt M; Grossmann C; Gekle M
    Hypertension; 2013 Feb; 61(2):333-40. PubMed ID: 23248150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine exacerbates pressure overload-induced cardiac remodeling.
    Netsu S; Shishido T; Kitahara T; Honda Y; Funayama A; Narumi T; Kadowaki S; Takahashi H; Miyamoto T; Arimoto T; Nishiyama S; Watanabe T; Woo CH; Takeishi Y; Kubota I
    Biochem Biophys Res Commun; 2014 Jan; 443(1):205-10. PubMed ID: 24291499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice.
    Ock S; Lee WS; Ahn J; Kim HM; Kang H; Kim HS; Jo D; Abel ED; Lee TJ; Kim J
    Endocrinology; 2016 Jan; 157(1):336-45. PubMed ID: 26469138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Galphaq mediated hypertrophy.
    Howes AL; Miyamoto S; Adams JW; Woodcock EA; Brown JH
    J Mol Cell Cardiol; 2006 May; 40(5):597-604. PubMed ID: 16466740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation.
    Morishige S; Takahashi-Yanaga F; Ishikane S; Arioka M; Igawa K; Kuroo A; Tomooka K; Shiose A; Sasaguri T
    Biochem Pharmacol; 2019 Oct; 168():82-90. PubMed ID: 31229551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.